The decrease was not of enough magnitude to have significantly less patients below risk cutoff values (0.24 for AIP, 36 for HSI), although the proportion of those who achieved this goal was higher in the non-CKD group (Supplementary Figures 2A, C). The gene discussed is AIP; the disease is chronic kidney disease.